Welcome to LookChem.com Sign In|Join Free
  • or
1-[(4-methoxyphenyl)methyl]-5,5-dimethylpyrrolidin-2-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1374244-41-3

Post Buying Request

1374244-41-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1374244-41-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1374244-41-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,4,2,4 and 4 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1374244-41:
(9*1)+(8*3)+(7*7)+(6*4)+(5*2)+(4*4)+(3*4)+(2*4)+(1*1)=153
153 % 10 = 3
So 1374244-41-3 is a valid CAS Registry Number.

1374244-41-3Downstream Products

1374244-41-3Relevant academic research and scientific papers

Simple and rapid p-methoxybenzylation of hydroxy and amide groups at room temperature by NaOt-Bu and DMSO

Hamada, Shohei,Sugimoto, Koichi,Iida, Masashi,Furuta, Takumi

, (2019)

The p-methoxybenzylation of hydroxy and amide groups by p-methoxybenzyl chloride utilizing NaOt-Bu in DMSO is described. p-Methoxybenzylation of sterically hindered menthol using NaOt-Bu in DMSO proceeded faster than the commonly used methods which use Na

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

-

Paragraph 00157-00159, (2021/02/19)

This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.

PROCESS OF MAKING CFTR MODULATORS

-

Paragraph 0740, (2021/02/19)

The disclosure provides processes for synthesizing Compound I, and pharmaceutically acceptable salts thereof.

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

-

Paragraph 0325; 0326, (2021/02/19)

This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical composi

HISTONE METHYLTRANSFERASE INHIBITORS

-

Page/Page column 93, (2018/07/29)

The present disclosure provides certain angular tricyclic compounds that are histone methyltransi erases G9a and/or GLP inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of G9a and/or GLP such as cancers and hemoglobinpathies (e.g., beta- thalassemia and sickle cell disease). Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.

Highly selective intramolecular carbene insertion into primary C-H bond of α-diazoacetamides mediated by a (p-cymene)ruthenium(II) carboxylate complex

Lo, Vanessa Kar-Yan,Guo, Zhen,Choi, Matthew Kwok-Wai,Yu, Wing-Yiu,Huang, Jie-Sheng,Che, Chi-Ming

, p. 7588 - 7591 (2012/07/02)

Complex [(p-cymene)Ru(η1-O2CCF3) 2(OH2)] mediated transformation of α-diazoacetamides ArCH2N(C(CH3)3)C(O)CHN2 to result in carbene insertion into the primary C-H bond exclusively, with the γ-lactam products being isolated in up to 98% yield. This unexpected reaction is striking in view of the presence of usually more reactive sites such as secondary C-H bonds in the substrates. DFT calculations based on proposed Ru-carbene species provide insight into this unique selectivity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1374244-41-3